Breath Actuated Nebulizer Study Protocol
NCT00382447 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2012-12-13
Summary
Comparison of the researchers' standard nebulizer and a breath actuated nebulizer to examine if breathing medication can be delivered more quickly and as effectively or more effectively than the standard nebulizer.
Conditions
Interventions
- DEVICE
-
standard nebulizer
Standard small volume nebulizer for aerosolized medication delivery
- DEVICE
-
breath actuated nebulizer
Nebulizer that dispenses medication only during the inspiratory phase
Sponsors & Collaborators
-
Christiana Care Health Services
lead OTHER
Principal Investigators
-
John S. Emberger, BS · Christiana Care Health Services
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-10-31
- Primary Completion
- 2008-06-30
- Completion
- 2008-06-30
Countries
- United States
Study Locations
More Related Trials
-
Effectiveness and Cost Study Comparing Two Ways to Deliver Albuterol for the Treatment of Asthma in the Hospital
NCT00623688 ·Status: COMPLETED ·Phase: NA
-
3D-Printed Aerosolized Medication Delivery Assist Device in Patients With Chronic Respiratory Diseases
NCT06315374 ·Status: WITHDRAWN ·Phase: NA
-
Trial of AccuPAP Device Versus Standard Nebulizer Therapy in Acute Asthma Exacerbation in Children
NCT02458482 ·Status: WITHDRAWN ·Phase: NA
-
Exhaled Nitric Oxide in Asthma Management
NCT02140684 ·Status: SUSPENDED
-
Aerosol Delivery in Different Types of Nebulizers
NCT02764307 ·Status: COMPLETED ·Phase: NA
-
Airway Temperature
NCT02401074 ·Status: WITHDRAWN ·Phase: PHASE1
-
Nebulizer Intervention for Minority Children With Asthma
NCT00218816 ·Status: COMPLETED ·Phase: PHASE3
-
12-Week Study in Adult Subjects With Asthma
NCT01516073 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Single-Dose Efficacy of an Albuterol Breath-Actuated Inhaler (Albuterol-HFA-BAI) Versus an Albuterol Metered-Dose Inhaler (Albuterol-HFA-MDI) in Participants With Asthma
NCT00530062 ·Status: COMPLETED ·Phase: PHASE4
-
Mucociliary Clearance in Healthy Subjects: Comparison of Levalbuterol and Racemic Albuterol
NCT00325767 ·Status: COMPLETED ·Phase: PHASE4
-
AeroEclipse II Agreement
NCT01288482 ·Status: COMPLETED ·Phase: PHASE4
-
Inhaled Dose Analysis Using a Breath Actuated Nebulizer in Healthy Subjects
NCT06157515 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of the Aeroneb in Acute Severe Asthma
NCT03029156 ·Status: COMPLETED ·Phase: NA
-
Early Antiinflammatory Treatment of Asthma
NCT00567463 ·Status: TERMINATED ·Phase: NA
-
Efficacy Study of Single-Dose Levalbuterol Tartrate HFA MDI Vs Placebo in Subjects 18 Years and Older With EIB
NCT00268723 ·Status: COMPLETED ·Phase: PHASE3
-
Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Racemic Albuterol in Pediatric Subjects
NCT00685347 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects Of Methacholine Challenge Administered Using Three Different Nebulizers On Small Airways Function
NCT00529477 ·Status: COMPLETED ·Phase: NA
-
Development and Validation of a Sputum Biomarker mRNA Panel for the Diagnostic Work-up of Asthma 3
NCT01224964 ·Status: TERMINATED ·Phase: NA
-
Study Evaluating the Safety and Effects of MN-221 in Subjects Experiencing an Acute Exacerbation of Asthma
NCT00683449 ·Status: TERMINATED ·Phase: PHASE2
-
A 12-Week Study in Adult Subjects With Asthma
NCT01516086 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized Trial Comparing Metered Dose Inhalers and Breath Actuated Nebulizers
NCT02777125 ·Status: COMPLETED ·Phase: NA
-
Implementing a Guidelines-Based M-Health Intervention for High Risk Asthma Patients
NCT03842033 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma
NCT00073827 ·Status: COMPLETED ·Phase: PHASE3
-
Cross-Over Study of Subcutaneous Study Drug for the Treatment of Patients With Mild to Moderate Asthma
NCT01304628 ·Status: WITHDRAWN ·Phase: PHASE2
-
Intervention to Improve Inhalative Adherence
NCT02386722 ·Status: COMPLETED ·Phase: NA